Loading…
CSBR
Champions Oncology Inc
NASDAQ· Healthcare· Biotechnology· CUSIP 15870P307
$4.93-1.79%Price as of Aug 29, 18:34 UTC · updated once a day, after the close
Key metrics
- Market cap
- $68.5M
- P/E
- —
- Forward P/E
- 49.3x
- P/B
- 17.4x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.08
- ROE
- -29.97%
- Profit margin
- -1.98%
- Revenue growth
- +12.00%
- Beta
- 0.41
- 52-week high
- $8.74
- 52-week low
- $4.83
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -49.8% over 5Y.
today you would have $479.92▼ -52.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 16 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $4.90 | $6.91 | $8.57 | $5.62 | $4.51 | $8.36 | $10.79 | $8.33 | $7.81 | $3.88 | $2.53 | $3.57 | $6.00 | $14.40 | $3.60 | $9.00 | |
| P/E | — |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
$0.60
Sector median of 13.3x operating profit, less net debt. Sees the business before its financing, so debt does not distort the comparison. Banks have no EBITDA — interest is their revenue, not a cost.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MDXHMDxHealth SA | $0.72 | — | — | — | — | $68.77M |
| XBITXBiotech Inc. | $2.27 | — | 0.5x | — | -29.94% | $69.21M |
| IBIOiBio, Inc. | $1.36 | — | 0.6x | — | -62.09% | $67.56M |
| PLRXPliant Therapeutics Inc | $1.13 | — |
About the company
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
- 214
- Hackensack, United States
Company description provided by Yahoo Finance.